The Cancer Prevention and Research Institute of Texas has hired a former biotech executive as its new chief product development officer. Michael Lang formerly had leadership positions NanoVision, a Pennsylvania cancer diagnostics company, and Dallas-based Galt Medical, a medical device company. He succeeds Tom Goodman, a former vice president of business development at Arizona Technology Enterprises—the tech transfer arm of Arizona State University and the Arizona Biodesign Institute—who left the agency in June after one year. CPRIT says it has awarded 27 product development grants totally more than $250 million since the agency was founded in 2009.
Author: Angela Shah
Angela Shah was formerly the editor of Xconomy Texas. She has written about startups along a wide entrepreneurial spectrum, from Silicon Valley transplants to Austin transforming a once-sleepy university town in the '90s tech boom to 20-something women defying cultural norms as they seek to build vital IT infrastructure in a war-torn Afghanistan. As a foreign correspondent based in Dubai, her work appeared in The New York Times, TIME, Newsweek/Daily Beast and Forbes Asia.
Before moving overseas, Shah was a staff writer and columnist with The Dallas Morning News and the Austin American-Statesman. She has a Bachelor's of Journalism from the University of Texas at Austin, and she is a 2007 Knight-Wallace Fellow at the University of Michigan. With the launch of Xconomy Texas, she's returned to her hometown of Houston.
View all posts by Angela Shah
